MSD & Co and Moderna have advanced a combination of an mRNA-based cancer vaccine and checkpoint inhibitor Keytruda into a phase 3 trial in skin cancer melanoma, althou
Uniting technical mRNA specialists in Europe for the very first time, the inaugural mRNA Analytical Development Summit Europe will bring 80+ Analytical Development, CMC, Quality, and Regula
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
